Sign in
Taking people in United StatesNo phase

Testing Meal Timing to Support Health in Night Shift Nurses

Tests timing of eating in night shift nurses and assistants who have overweight or obesity.

Key facts

Who runs it
Salk Institute for Biological Studies
Where
La Jolla, United StatesSee the site
Trial code
Registry title
Optimization of Chrononutrition to Reduce the Risk of Disease in Shift Workers
Status
Recruiting
People taking part
180 people, planned
Started
2 Jun 2025
Expected to end
3 Mar 2029
Type of study
Interventional, 3 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Dietary Monitoring
  • Time-Restricted Eating (TRE)
  • Time-Restricted Eating with a Low-Glycemic Snack (TRE-LGS)
Record updated
17 December 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for night shift nurses and nursing assistants with extra weight who eat over a window of 14 hours or more a day. It tests eating within a set daytime window.

Age
18 to 70 years
Sex
All sexes can join.
Disease stage
BMI of 25 kg/m2 or more (23 kg/m2 or more for Asian adults). People with type 2 diabetes can join if A1c is less than 9 and they do not use insulin.
Earlier treatment
Must have worked night shifts for at least 3 months. Must not have used sulfonylurea or insulin in the last 3 months, nor weight-loss drugs such as SGLT2 inhibitors or GLP1 receptor agonists.

Main reasons for not taking part

  • Type 1 diabetes or insulin-dependent type 2 diabetes
  • BMI over 50 kg/m2
  • Pregnant, breastfeeding or trying to become pregnant
  • Heart attack, stroke or heart failure hospital stay in the past year
  • Already in a weight-loss or weight-management program

The registry criteria, word for word

Show all 35 criteriaShow less

Who can take part

  • Age: 18-70 years
  • BMI ≥ 25 kg/m2 (or ≥ 23 kg/m2 for Asian adults)
  • Own a smartphone (Apple iOS or Android OS)
  • Baseline eating window ≥ 14 h/day
  • Night shift nurses and nursing assistants who are working a 12-hour night shift at least 3 days/week
  • Have been doing night shift work for at least 3 months
  • Patients on cardiovascular medications (HMG CoA reductase inhibitors (statins), metformin, lipid-modifying drugs (including over-the-counter drugs such as red yeast rice and fish oil), anti-hypertensive, drugs), are allowed
  • If patients have Type 2 Diabetes, they will be included in the study if A1c is less than 9 and they are not on insulin

Who cannot take part

  • Use of medications that are known to cause weight loss such as SGLT2 inhibitors and GLP1 receptor agonists)
  • Change in medications that could impact study outcomes within the past 3 months
  • Uncontrolled psychiatric disorder including prior hospitalization
  • Type 1 Diabetes or Insulin-dependent Type 2 Diabetes
  • Active tobacco abuse or illicit drug use or history of treatment for alcohol abuse in the past 5 years
  • Active treatment for inflammatory and/or rheumatologic disease
  • History of a major adverse cardiovascular event within the past year (acute coronary syndrome, percutaneous coronary intervention, coronary artery bypass graft surgery, hospitalization for congestive heart failure, stroke/transient ischemic attack)
  • Uncontrolled arrhythmia (i.e. rate-controlled atrial fibrillation/atrial flutter are acceptable)
  • History of thyroid disease requiring dose titration of thyroid replacement medication(s) within the past 3 months (hypothyroidism on a stable dose of thyroid replacement therapy is allowed)
  • History of adrenal disease in the past 5 years
  • History of malignancy undergoing active treatment, except non-melanoma skin cancer, in the past 5 years
  • History of an eating disorder in the past 5 years
  • History of cirrhosis in the past 5 years
  • History of stage 4 or 5 chronic kidney disease or dialysis in the past 5 years
  • History of HIV/AIDs
  • History of surgical intervention for weight management within the past 2 years, or longer if deemed unsafe following review by medical investigators
  • Fasting LDL cholesterol greater than 250 mg/dL
  • Insufficient dietary logging on the mCC app is defined as less than 7 of 14 days of baseline of dietary logging with a minimum of 2 items a day, at least 5 hours apart
  • Use of sulfonylurea or insulin within the last 3 months (due to unknown safety with TRE)
  • BMI > 50 kg/m2
  • Change in weight of >4kg in the past 3 months
  • Women who are pregnant, breastfeeding, or are trying to become pregnant during the study period. If a participant becomes pregnant during the study, they will be excluded from continuing the study
  • Systolic BP greater than 160 mmHg and/or diastolic BP greater than 110 mmHg at rest
  • Fasting triglycerides greater than 500g/dL
  • Frequent (more than 4) travel involving a time zone change of more than 3 hours over the 1-year study period
  • Prolonged leave from work (a continuous month or longer) during the study
  • Currently enrolled in weight-loss or weight-management program

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 70 years old?

Where in United States

  • University of California, San Diego Altman Clinical and Translational Research InstituteLa Jolla, United StatesContact: UCSD Study CoordinatorTaking people

About the trial

What the trial wants to find out

In this randomized controlled trial, the investigators will assess the health impacts of optimizing the timing of dietary consumption in nurses and nursing assistants who work night shifts, have a habitual eating window of 14 hours or more, and elevated weight. Participants will be randomized to one of three groups: (1) dietary monitoring, (2) dietary monitoring plus 10-hour daytime time-restricted eating (TRE), or (3) TRE with a low-glycemic snack during night shifts. The study includes a 2-week screening/baseline health assessment, with follow-up health assessments at 3-, 6- (primary outcome), and 12 months.

The 3 groups in the trial

  • Dietary MonitoringExisting treatment, for comparison

    Log all dietary intake and continue habitual eating patterns.

  • Time-Restricted Eating (TRE)Treatment being tested

    Dietary Monitoring and adherence to a personalized consistent 10-hour time-restricted eating window

  • Time-Restricted Eating with Low-Glycemic Snack (TRE-LGS)Treatment being tested

    Dietary Monitoring and adherence to a modified personalized consistent 10-hour time-restricted eating window a low-glycemic snack provided by the research team to consume during night shifts.

    Treatment: Time-Restricted Eating with a Low-Glycemic Snack (TRE-LGS)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Optimization of Chrononutrition to Reduce the Risk of Disease in Shift Workers - The SHIFT Study
Plain-language title
Testing Meal Timing to Support Health in Night Shift NursesGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT06891352, who can take part
Record updated
17 December 2025